Stock AnalizKoninklijke Philips NV PHG
Medical Electronics · data as of November 13, 2026
Koninklijke Philips NV (PHG) is a healthcare company listed in the US with a market value of about $29.8B. In the twelve months to September 30, 2026 it had revenue of $19.6B and net income of $1.1B, a net margin of 5.4%.
Its overall Stock Analiz score is 1.6 out of 5 (weak). The strongest part is shareholder returns (3/5); the weakest is track record (0/5).
Key numbers: a P/E of 63.2, a price to free cash flow of 14.8, 5-year revenue growth of -0% a year, a 5-year average ROIC of 1%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 51% below the current price.
Score: 1.6 / 5
Checks passed
- P/FCF below 20
- Revenue growth above 10% last year
- Profit margin improving
- Positive free cash flow
- Liabilities below 60% of assets
- Pays a dividend
- Dividend 3 years in a row
- Stock-based pay below 5% of revenue
Checks not passed
- P/E below 25
- P/E below the industry median
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- 3-year revenue growth above 10% a year
- 3-year free cash flow growth above 10% a year
- Strong R&D investment or growth above 20%
- 5-year EPS growth above 10% a year
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $19.6B | $21.0B | $18.7B | $20.1B | $19.0B | $19.4B | $21.2B | $19.3B | $20.7B | $21.3B | $18.4B |
| Net income | $1.1B | $1.1B | -$729M | -$515M | -$1.7B | $3.8B | $1.5B | $1.3B | $1.2B | $2.0B | $1.5B |
| Free cash flow | $2.0B | — | — | — | — | — | — | — | — | — | — |
| EPS (diluted) | $1.08 | $1.07 | $-0.74 | $-0.52 | $-1.75 | $3.82 | $1.48 | $1.33 | $1.27 | $2.02 | $1.55 |
| Net margin | 5.4% | 5.0% | -3.9% | -2.6% | -9.0% | 19.4% | 6.9% | 6.8% | 6.0% | 9.3% | 8.3% |
| ROIC | — | 5.7% | 2.1% | -0.5% | -6.7% | 2.0% | 5.5% | 6.0% | 8.9% | 6.8% | 6.5% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
What is Koninklijke Philips NV’s P/E ratio?
About 63.2, based on the last twelve months of diluted earnings per share (forward P/E about 14.7).
Is Koninklijke Philips NV stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 51% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Koninklijke Philips NV pay a dividend?
Yes. The dividend yield is about 3.35%, and it has paid dividends for 9 years in our data.
Is Koninklijke Philips NV a good stock to buy?
We do not give buy or sell advice. Koninklijke Philips NV scores 1.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.